Abstract:mu-SIIIA, a novel mu-conotoxin from Conus striatus, appeared to be a selective blocker of tetrodotoxin-resistant sodium channels in frog preparations. It also exhibited potent analgesic activity in mice, although its selectivity profile against mammalian sodium channels remains unknown. We have determined the structure of mu-SIIIA in aqueous solution and characterized its backbone dynamics by NMR and its functional properties electrophysiologically. Consistent with the absence of hydroxyprolines, mu-SIIIA adopts a single conformation with all peptide bonds in the trans conformation. The C-terminal region contains a well-defined helix encompassing residues 11-16, while residues 3-5 in the N-terminal region form a helix-like turn resembling 3 10-helix. The Trp12 and His16 side chains are close together, as in the related conotoxin mu-SmIIIA, but Asn2 is more distant. Dynamics measurements show that the N-terminus and Ser9 have larger-magnitude motions on the subnanosecond time scale, while the C-terminus is more rigid. Cys4, Trp12, and Cys13 undergo significant conformational exchange on microsecond to millisecond time scales. mu-SIIIA is a potent, nearly irreversible blocker of Na V1.2 but also blocks Na V1.4 and Na V1.6 with submicromolar potency. The selectivity profile of mu-SIIIA, including poor activity against the cardiac sodium channel, Na V1.5, is similar to that of the closely related mu-KIIIA, suggesting that the C-terminal regions of both are critical for blocking neuronal Na V1.2. The structural and functional characterization described in this paper of an analgesic mu-conotoxin that targets neuronal subtypes of mammalian sodium channels provides a basis for the design of novel analogues with an improved selectivity profile.

Molecular Basis for Pore Blockade of Human Na+ Channel Nav1.2 by the Μ-Conotoxin KIIIA

Structural basis for pore blockade of the human cardiac sodium channel Nav1.5 by tetrodotoxin and quinidine

Structures of Human Nav1.7 Channel in Complex with Auxiliary Subunits and Animal Toxins.

Structure of human NaV1.6 channel reveals Na<sup>+</sup>selectivity and pore blockade by 4,9-anhydro-tetrodotoxin

Structure of human NaV1.6 channel reveals Na+ selectivity and pore blockade by 4,9-anhydro-tetrodotoxin

Closed-state inactivation and pore-blocker modulation mechanisms of human CaV2.2

Structure, dynamics, and selectivity of the sodium channel blocker mu-conotoxin SIIIA

Design, synthesis, and mechanism of action of novel μ-conotoxin KIIIA analogues for inhibition of the voltage-gated sodium channel Nav1.7

Structural basis for Na V 1.7 inhibition by pore blockers

Structure of the Human Voltage-Gated Sodium Channel Nav1.4 in Complex with Β1.

Structural Basis for Pore Blockade of the Human Cardiac Sodium Channel Nav1.5 by the Antiarrhythmic Drug Quinidine**

Structural basis for high-voltage activation and subtype-specific inhibition of human Na<sub>v</sub>1.8

Structural basis for high-voltage activation and subtype-specific inhibition of human Na v 1.8.

Cryo-EM structure of human voltage-gated sodium channel Nav1.6

High-resolution Structures of Human Nav1.7 Reveal Gating Modulation Through Α-Π Helical Transition of S6IV.

Cryo-EM structure of human voltage-gated sodium channel Na <sub>v</sub> 1.6

Structure of human Cav2.2 channel blocked by the painkiller ziconotide

MinK Residues Line a Potassium Channel Pore

Structural basis for the modulation of voltage-gated sodium channels by animal toxins

Structural basis of inhibition of human NaV1.8 by the tarantula venom peptide Protoxin-I

A novel conotoxin from Conus striatus, μ-SIIIA, selectively blocking rat tetrodotoxin-resistant sodium channels